Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease
Year: 2019
Type: article
Source: Circulation
Authors: Suzanne V. Arnold, James A. de Lemos, Robert S. Rosenson, Christie M. Ballantyne, Yuyin Liu, Katherine E. Mues, Shushama Alam, Mary Elliott-Davey, Deepak L. Bhatt, Christopher P. Cannon, Mikhail Kosiborod, On behalf of the GOULD Investigators
Institutions: Saint Luke's Hospital, University of Missouri–Kansas City, The University of Texas Southwestern Medical Center, Icahn School of Medicine at Mount Sinai, Baylor College of Medicine, Baim Institute for Clinical Research, Amgen (United States), Brigham and Women's Hospital, Harvard University, The George Institute for Global Health
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2954229159